The DOI matches its Crossref record; 250 of the 255 references it cites were found in a registry or an index.
2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“People with diabetes may present with a wide spectrum of heart failure, including heart failure with preserved ejection fraction (HFpEF), heart failure with mildly reduced ejection fraction (HFmrEF), or heart failure with reduced ejection fraction (HFrEF) (12,13).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Self-citationEmpagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Human agency in social cognitive theory.
Bandura, A. (1989) · American Psychologist · doi:10.1037/0003-066x.44.9.1175 · Cited by 8,263
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
Angiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382
Flagged first, then by citations
5 of the 255 references couldn’t be matched to a known paper.
Research works printed but not linked: 12
- Desai, 2019, Effect of sacubitril-valsartan vs enalapril on aortic stiffness in patients with heart failure and reduced ejection fraction: a randomized clinical trial, JAMA, 1
- Mann, 2020, Sacubitril/valsartan in advanced heart failure with reduced ejection fraction: rationale and design of the LIFE Trial, J Am Coll Cardiol HF, 8, 789
- Solomon, 2020, Effect of dapagliflozin in patients with hfref treated with sacubitril/valsartan: the DAPA-HF Trial, J Am Coll Cardiol HF, 8, 811
- DeFilippis, 2020, Considerations for heart failure during the COVID-19 pandemic, J Am Coll Cardiol HF, 8, 681
- Daubert, 2019, NT-proBNP goal achievement is associated with significant reverse remodelings and improved clinical outcomes in HFrEF, J Am Coll Cardiol HF, 7, 158
- Myhre, 2022, Early B-Type natriuretic peptide change in HFrEF patients treated with sacubitril/valsartan: a pooled analysis of EVALUATE-HF and PROVE-HF, J Am Coll Cardiol HF, 10, 119
- McAlister, 2004, Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials, J Am Coll Cardiol, 44, 810
- Vaduganathan, 2020, Contemporary treatment patterns and clinical outcomes of comorbid diabetes mellitus and HFrEF: The CHAMP-HF Registry, J Am Coll Cardiol HF, 8, 469
- Berardi, 2020, Angiotensin-neprilysin inhibition in Black Americans: data from the PIONEER-HF Trial, J Am Coll Cardiol HF, 8, 859
- Pandey, 2019, Frailty is interwined with heart failure: mechanisms, prevalence, prognosis, assessment and management, J Am Coll Cardiol HF, 7, 1001
- Mozaffarian, 2016, Heart disease and stroke statistic - 2016 update: a report from the American Heart Association, Circulation, 133, e38
- 2023, Standards of Medical Care in Diabetes-2024, Diabetes Care, 47, Suppl 1
Cited by
Sorted by citations
Items 301–325 of 325
Impact of SARS-CoV-2 infection and viral burden on outcomes in acute decompensated heart failure
Nashtar, M. A., Sehovic, H., Salemdawod, M., Garipoglu, G., Ödemis, B., Tzalavras, A., Steinmetz, M., Canbay, A., Özcürümez, M. K., Varnavas, V., et al. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-14407-y
Abdelnabi, M., Pham, H. N., Ibrahim, R., Allam, M., Pathangey, G., Tan, M. C., Lee, K., Fortuin, F. D., Alsidawi, S., Ayoub, C., et al. (2026) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001936
Sun, X., Tang, X., Jin, M., Yuan, W., & Yuan, G. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1901876
Management of patients with cardiopulmonary comorbidities awaiting liver transplantation
Liu, A., & Izzy, M. J. (2026) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000001312
Assessment of the need for sodium-glucose cotransporter 2 inhibitors in the Republic of Uzbekistan
Umarova, S. Z., Sultanbayeva, N. M.-U., & Iskandarova, S. F. (2026) · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · doi:10.17749/2070-4909/farmakoekonomika.2026.368
Donay, B. G., Magedanz, E. H., Gustavo, A. D. S., & Bodanese, L. C. (2026) · PAJAR - Pan-American Journal of Aging Research · doi:10.15448/2357-9641.2026.1.49434
Al-Bawalsah, T. B., Abed, A. I., Alsa’d, A. A., & Shilbayeh, S. A. R. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15197569
Pezzi, L., Rossi, D., Magnano, R., Saraullo, S., D’Alleva, A., Marino, M. D., Scollo, C., Pierfelice, F., Genovesi, E., Renda, G., et al. (2026) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2026.103473
Yuan, W., Zhou, B., & Yu, C. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1954549
Emerging links between TLR4 signaling and ferroptosis in heart failure
Wang, C., Huang, X., Zhang, Z., Hu, Y., Lin, D., & Huang, S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1909522
Nurse led titration of guideline-directed medical therapy for heart failure: an operative flow chart
Gori, M., Barisone, M., Maria, R. D., Fazzini, L., Spagnolin, M., Rizzello, V., Marchesi, M., Pini, D., Radini, D., D’Elia, E., et al. (2026) · ESC Heart Failure · doi:10.1093/eschf/xvag223
Imamura, T. (2026) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-026-07975-3
Diretriz Brasileira de Insuficiência Cardíaca – 2026
Simões, M. V., Moura, L. Z., Martins, S. M., Mourilhe‐Rocha, R., Danzmann, L. C., Neto, J. A. D. F., Marcondes‐Braga, F. G., de Oliveira, M. T., de Albuquerque, D. C., Freitas, A. F., et al. (2026) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20260830
Atrial Fibrillation and Cardiomyopathy Secondary to Alcohol Use
Andersson, C., & Monahan, K. M. (2026) · Springer eBooks · doi:10.1007/978-3-031-35658-2_89-1
Elbataa, A., Mansour, A., Elazab, A., Alabed, A., Masood, R. J., Albogami, A. F., Alsalami, J. A., Hafeezallah, A. O., Alzahrani, K. M., Alotaibi, K. F., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71411
Alonayzan, R. O., Alsa’d, A. A., Zakaraya, Z. Z., Malouh, M. A., Abed, A. I., & AlRasheed, H. A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15208001
Putri, A. S., Rahmawati, F., & Nugroho, A. E. (2026) · Journal of Pharmaceutical And Sciences · doi:10.36490/journal-jps.com.v9i4.1898
Bechthold, A. C., McIlvennan, C. K., Wells, R. D., Saylor, M. A., Moser, D. K., Matlock, D. D., & Dionne-Odom, J. N. (2026) · Heart & Lung · doi:10.1016/j.hrtlng.2026.102974
Zhong, R., Lin, Q., Huang, H., & Cheng, X. (2026) · Research Square · doi:10.21203/rs.3.rs-11050939/v1
Adjeroh, L., Kamal, K. M., Guo, L. R., Balla, S., Wen, S., & Kido, K. (2026) · Annals of Pharmacotherapy · doi:10.1177/10600280261493520
Salameh, E., Hoballah, M., Ebrahimihoor, E., Zadeh, A., Schuijf, J. D., & Lima, J. A. C. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1946683
Genetic Pulmonary Hypertension Combined With Biventricular Heart Failure
Danh, V. D., Nguyen, Q. Q., & Nguyen, H. T. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2026.110839
Tsalouchos, A., & Dattolo, P. C. G. (2026) · Heart Failure Reviews · doi:10.1007/s10741-026-10689-1
Pharmacist-Led Medication Titration for Cardiometabolic Disease: Evidence, Equity, and Scale
Yarlagadda, S., & Blood, A. J. (2026) · Current Cardiology Reports · doi:10.1007/s11886-026-02432-x
Miteva, K., & Mach, F. (2026) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000001063 · Cited by 1
Metadata
- Authors
- Maddox, T. M., Januzzi, J. L., Allen, L. A., Breathett, K., Brouse, S., Butler, J., Davis, L. L., Fonarow, G. C., Ibrahim, N. E., Lindenfeld, J., Masoudi, F. A., Motiwala, S. R., Oliveros, E., Walsh, M. N., Wasserman, A., Yancy, C. W., & Youmans, Q. R.
- ORCID
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2024-04
- Volume
- 83
- Issue
- 15
- Pages
- 1444-1488
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W4392581840
- Cited by
- 362
- References
- 255
- Citations by year
- 2026: 181 · 2025: 133 · 2024: 48
- FWCI
- 100.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- heart failure with reduced ejection fraction, expert consensus, heart failure treatment, guideline recommendations
- MeSH terms
- Cardiology, Cardiovascular System, Heart Failure, Humans, Stroke Volume, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
